Business
Taysha Gene Therapies to Participate in Upcoming May Investor Healthcare Conferences
2021 RBC Capital Markets Global Healthcare Conference on May 19, 2021 at 3:05 pm ET Oppenheimer Rare & Orphan Disease Summit on Friday May 21, 2021 at 4:35
About this update from Taysha Gene Therapies, Inc.
[{"type":"text","content":"\n 2021 RBC Capital Markets Global Healthcare Conference on May 19, 2021 at 3:05 pm ET\n\nOppenheimer Rare & Orphan Disease Summit on Friday May 21, 2021 at 4:35 pm ET\n\n DALLAS--(BUSINESS WIRE)--\nTaysha Gene Therapies, Inc. (Nasdaq: TSHA), a patient-centric, clinical-stage gene therapy company focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the central nervous system (CNS) in both rare and large patient populations, today announced its participation in a virtual fireside chat at the 2021 RBC Capital Markets Global Healthcare Conference and a virtual presentation at the Oppenheimer Rare & Orphan Disease Summit.\n\n\n\nConference Details:\n\n\n\n\n\nEvent:\n\n\n\n\n2021 RBC Capital Markets Global Healthcare Conference\n\n\n\n\n\nDate:\n\n\n\n\nWednesday, May 19, 2021\n\n\n\n\n\nTime:\n\n\n\n\n3:05 pm ET\n\n\n\n\n\nFormat:\n\n\n\n\nFireside chat\n\n\n\n\n\nParticipants:\n\n\n\n\nRA Session II, President, Founder and CEO\n\n\n\n\n\n \n\n\n\n\nDr. Suyash Prasad, Chief Medical Officer and Head of Research and Development\n\n\n\n\n\n \n\n\n\n\nKamran Alam, Chief Financial Officer\n\n\n\n\n\n \n\n\n\n\n \n\n\n\n\n\nEvent:\n\n\n\n\nOppenheimer Rare & Orphan Disease Summit\n\n\n\n\n\nDate:\n\n\n\n\nFriday, May 21, 2021\n\n\n\n\n\nTime:\n\n\n\n\n4:35 pm ET\n\n\n\n\n\nFormat:\n\n\n\n\nPresentation\n\n\n\n\n\nParticipants:\n\n\n\n\nRA Session II, President, Founder and CEO\n\n\n\n\n\n \n\n\n\n\nDr. Suyash Prasad, Chief Medical Officer and Head of Research and Development\n\n\n\n\n\n \n\n\n\n\nKamran Alam, Chief Financial Officer\n\n\n\n\nWebcasts for these conferences will be available in the “Events & Media” section of the Taysha corporate website at https://ir.tayshagtx.com/news-events/events-presentations. Archived versions of the webcasts will be available on the website for 60 days.\n\nAbout Taysha Gene Therapies \n\nTaysha Gene Therapies (Nasdaq: TSHA) is on a mission to eradicate monogenic CNS disease. With a singular focus on developing curative medicines, we aim to rapidly translate our treatments from bench to bedside. We have combined our team’s proven experience in gene therapy drug development and commercialization with the world-class UT Southwestern Gene Therapy Program to build an extensive, AAV gene therapy pipeline focused on both rare and large-market indicat...